Selacholine (75Se)

What is Selacholine (75Se)?

Selacholine (75Se), also known by its full chemical designation as Selenium (75Se) tauroselcholic acid, is a specialized **diagnostic radiopharmaceutical** used in nuclear medicine. It is a synthetic bile acid analogue labeled with a radioactive isotope, Selenium-75 (Selenium-75). This compound is designed to mimic the behavior of natural bile acids within the human body, allowing medical professionals to track its movement and absorption, primarily within the gastrointestinal system. Its unique properties make it an invaluable tool for diagnosing specific conditions related to bile acid metabolism and absorption.

As a radiotracer, Selacholine (75Se) emits gamma rays, which can be detected externally by specialized imaging equipment, such as gamma cameras. This non-invasive approach provides functional information about the digestive system, particularly the small intestine's ability to reabsorb bile acids. While not a treatment, its diagnostic capabilities are crucial for guiding therapeutic decisions for patients suffering from chronic gastrointestinal issues.

How Does it Work?

The mechanism of action for Selacholine (75Se) is rooted in its structural similarity to natural bile acids. After oral administration, it travels through the digestive tract. Like endogenous bile acids, it is designed to be efficiently absorbed in the terminal ileum, the last part of the small intestine. Once absorbed, it enters the **enterohepatic recirculation** system, where it is transported to the liver, secreted back into the bile, and then re-enters the small intestine. This cyclical process is vital for fat digestion and absorption.

The critical difference is the attached Selenium-75 isotope. This radioactive tag allows for external detection throughout its journey. Selenium-75 is a gamma-emitting isotope with a half-life of approximately 119.8 days, which is long enough for multi-day diagnostic studies but short enough to minimize long-term radiation exposure. By monitoring the retention and excretion of the labeled bile acid over time, clinicians can assess the integrity and function of the ileal absorption process. A reduced retention of Selacholine (75Se) in the body indicates impaired ileal reabsorption, which is a hallmark of **bile acid malabsorption**.

Medical Uses

The primary medical application of Selacholine (75Se) is the diagnosis of **bile acid malabsorption** (BAM). This condition occurs when the terminal ileum fails to adequately reabsorb bile acids, leading to an excess of bile acids entering the colon, which can cause chronic diarrhea, abdominal pain, and bloating. Conditions commonly associated with BAM that can be diagnosed using Selacholine (75Se) include:

• Crohn's disease: Particularly in cases affecting the ileum, leading to inflammation and damage.
• Ileal resection: Patients who have undergone surgical removal of part of the ileum.
• Radiation enteritis: Damage to the small intestine from radiation therapy.
• Chronic idiopathic diarrhea: When other causes have been ruled out, BAM can be a significant underlying factor.
• Irritable Bowel Syndrome with Diarrhea (IBS-D): A subset of patients with IBS-D have underlying BAM.
• Celiac disease and other malabsorption syndromes.

The test involving Selacholine (75Se), often referred to as the SeHCAT test (Selenium Homocholic Acid Taurine test), helps differentiate between various causes of chronic diarrhea and guides appropriate treatment, such as bile acid sequestrants.

Dosage

The administration of Selacholine (75Se) is strictly controlled and performed by trained nuclear medicine specialists. The dosage is very small, typically in the range of 37 to 185 kilobecquerels (kBq), or 1 to 5 microcuries (µCi), for adults. It is usually given orally, often as a capsule, with a small amount of water.

Patient preparation may include fasting for several hours before administration to ensure optimal absorption. After ingestion, measurements of the retained radioactivity are taken at specific intervals, most commonly at 7 days post-administration, though some protocols may include earlier scans at 24 or 48 hours. The percentage of retained radioactivity is then calculated to determine the presence and severity of bile acid malabsorption. Due to the radioactive nature of the compound, careful handling and disposal procedures are followed to ensure patient and staff safety.

Side Effects

Selacholine (75Se) is generally considered very safe, and side effects are rare due to the extremely low diagnostic dose administered. The amount of radioactive material and the radiation exposure are minimal, comparable to or even less than that from other common diagnostic imaging procedures like X-rays or CT scans. The benefits of an accurate diagnosis typically far outweigh the minimal risks involved.

However, as with any pharmaceutical, a remote possibility of adverse reactions exists. These might include very mild and transient gastrointestinal upset, such as nausea or abdominal discomfort, although these are exceedingly uncommon. Allergic reactions are exceptionally rare. Patients should inform their healthcare provider of any known allergies or sensitivities before undergoing the test.

Special precautions are taken for pregnant or breastfeeding women, as radiation exposure to a fetus or infant should be avoided. In such cases, the test is generally contraindicated, or alternative diagnostic methods are considered.

Drug Interactions

Direct drug interactions with Selacholine (75Se) itself are not a major concern, primarily because it is administered in minute diagnostic quantities and its purpose is to be traced, not to exert a pharmacological effect. However, certain medications can significantly interfere with the absorption or enterohepatic circulation of bile acids, thereby potentially affecting the accuracy of the Selacholine (75Se) test results.

Drugs that may influence test outcomes include:

• Bile acid sequestrants: Medications like cholestyramine or colesevelam, used to treat high cholesterol, bind to bile acids and prevent their reabsorption, which would lead to a falsely low retention of Selacholine (75Se).
• Certain antibiotics: Some antibiotics can alter gut flora, potentially affecting bile acid metabolism or absorption.
• Laxatives: Especially those that accelerate intestinal transit, could reduce the time for ileal absorption.
• Orlistat: A lipase inhibitor that reduces fat absorption, which might indirectly influence bile acid kinetics.

It is crucial for patients to inform their physician about all medications, supplements, and herbal remedies they are taking before undergoing the gastrointestinal imaging test to ensure accurate interpretation of the results and to avoid any potential interference.

FAQ

Q: Is Selacholine (75Se) a treatment for bile acid malabsorption?

A: No, Selacholine (75Se) is purely a diagnostic agent. It helps to identify if you have bile acid malabsorption, but it does not treat the condition itself. Treatment for BAM typically involves medications like bile acid sequestrants.

Q: How long does the SeHCAT test take?

A: The administration of the capsule is quick. However, the test requires you to return for scans at specific time points, usually at 7 days after ingestion, to measure the retention of the radiotracer. Some protocols may include earlier scans as well.

Q: What should I do to prepare for the test?

A: Your doctor or the nuclear medicine department will provide specific instructions. This may include fasting for a few hours before taking the capsule and avoiding certain medications that could interfere with the test results.

Q: What does a low retention percentage mean?

A: A low retention percentage of Selacholine (75Se) (e.g., less than 15% at 7 days) indicates that your body is not reabsorbing bile acids efficiently, which is consistent with a diagnosis of bile acid malabsorption.

Q: Is there a lot of radiation exposure from Selacholine (75Se)?

A: The radiation dose from Selacholine (75Se) is very low and considered safe for diagnostic purposes. It is comparable to or less than the radiation from other common medical imaging tests. The clinical benefits of an accurate diagnosis typically outweigh the minimal radiation risk.

Products containing Selacholine (75Se) are available through trusted online pharmacies. You can browse Selacholine (75Se)-based medications at ShipperVIP or Medicenter.

Summary

Selacholine (75Se) is a vital **diagnostic radiopharmaceutical** used in nuclear medicine to assess bile acid absorption and diagnose conditions like **bile acid malabsorption**. By mimicking natural bile acids and being labeled with **Selenium-75**, it allows clinicians to non-invasively track its enterohepatic circulation and identify impaired ileal function. While exceptionally safe with minimal side effects due to its low diagnostic dose, accurate interpretation of results requires careful consideration of potential drug interactions. This specialized test plays a crucial role in guiding effective management strategies for patients suffering from chronic gastrointestinal symptoms, ultimately improving patient care and quality of life.